🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
DBV
$DBV.PA
🔒 EuropeDBV Technologies
AVG HISTORICAL GAP
-0.69%
MAX GAP RECORD
-8.92%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $DBV.PA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$DBV.PA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 28, 2026 Earnings Release 2026-10-28 (AFTER CLOSE (16:00)) |
-8.92%
|
| Jul 16, 2026 Earnings Release 2026-07-16 (AFTER CLOSE) |
-4.92%
|
| Mar 26, 2026 Earnings Release 2026-03-26 (AFTER CLOSE) |
+2.12%
|
| Oct 28, 2025 Earnings Release 2025-10-28 (AFTER CLOSE) |
-3.87%
|
| Jul 29, 2025 Earnings Release 2025-07-29 (AFTER CLOSE) |
+4.04%
|
| May 07, 2024 Earnings Release 2024-05-07 (AFTER CLOSE) |
+1.47%
|
| Mar 07, 2024 Earnings Release 2024-03-07 (AFTER CLOSE) |
-1.23%
|
| Oct 31, 2023 Earnings Release 2023-10-31 (AFTER CLOSE) |
+1.02%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.9%
Bullish Gaps (5)
Bearish Gaps (4)
Neutral / Flat (2)
📖 Intelligence Summary
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗